Global /China /Healthcare /Drug Manufacturers - General /603567

Heilongjiang ZBD Pharmaceutical Co., Ltd.

603567

• SSE: 603567 • Delayed

7.08CNY 6.2%

1.05 USD

As of 14 June 2026, Heilongjiang ZBD Pharmaceutical Co., Ltd. has a market cap of $981.25M USD, ranking #10814 globally and #3042 in China. It ranks #967 in the Healthcare sector, and #358 in the Drug Manufacturers - General industry.

Global Rank

10814

Country Rank

3042

Sector Rank

967

Industry Rank

358

Key Stats

Market Cap

$981.25MUSD

6.65B CNY

Enterprise Value

$1.43BUSD

9.69B CNY

Revenue (TTM)

$117.78MUSD

798.06M CNY

EBITDA (TTM)

-$37.09MUSD

-250.98M CNY

Net Income (TTM)

-$201.67MUSD

-1.37B CNY

EBITDA Margin

-31%

Profit Margin

-171%

PS Ratio

8.3

PB Ratio

1.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jiujiang Yan open_in_new

Employees

2,349

Founded

1996

Website

zbdzy.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
6.2%	5.5%	0.6%	-18%	-37%	-21%	-33%	-57%	-52%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603567 黑龙江珍宝岛药业股份有限公司 Class A ISIN: CNE100002219 Shares Out.: Shares Outstanding: 939.403M¹ Shares Float: 343.502M² TV: TradingView: SSE: 603567 SA: Stock Analysis: SHA: 603567 YF: Yahoo Finance: 603567.SS GF: Google Finance: SHA: 603567 BA: Barron's: 603567 MS: Morningstar: XSHG: 603567	7.08 CNY	TV: TradingView: SSE: 603567 SA: Stock Analysis: SHA: 603567 YF: Yahoo Finance: 603567.SS GF: Google Finance: SHA: 603567 BA: Barron's: 603567 MS: Morningstar: XSHG: 603567

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Heilongjiang ZBD Pharmaceutical Co., Ltd.

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 5K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 5K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 78K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 56K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 37K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 33K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 29K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 28K%	20.5	Switzerland

chevron_leftBack